Skip to content

Clinical trials

Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: United States Clear all

1,393 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20023
200311
200413
200512
200624
200719
200823
200929
201029
201137
201238
201340
201440
201554
201657
201775
201883
201988
202065
2021130
2022105
2023116
202494
202593
202693

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed772
Recruiting237
Active, not recruiting102
Terminated91
Unknown status80
Not yet recruiting43
Enrolling by invitation34
Withdrawn31
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development34
University of California, San Francisco32
Johns Hopkins University31
Massachusetts General Hospital30
Wake Forest University Health Sciences27
Emory University24
University of Pennsylvania24
Indiana University23
Vanderbilt University Medical Center22
Mayo Clinic21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction1,393
Alzheimer Disease442
Dementia288
Memory Disorders99
Parkinson Disease47
Cognition Disorders44
Delirium44
Brain Injuries, Traumatic31
Schizophrenia30
Breast Neoplasms29

Trials

Showing 1 to 25 of 1,393. Each trial links to its page on Pharma Observatory.

1,293 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.